ORGO logo

Organogenesis Holdings (ORGO) Cash From Investing

Annual CFI

-$10.03 M
+$14.33 M+58.82%

December 31, 2024

Summary

Performance

1-Year Change

+58.82%

3-Year Change

+67.87%

5-Year Change

-60.92%

15-Year Change

+32.55%

ORGO Cash From Investing Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

33.5%
ORGO annual cash flow from investing activities is higher than 33.5% of companies in Healthcare sector

High & Low

All-time High

-$1.25 M

3-Year Low

-$33.90 M

Earnings dates

Last Annual Earnings Report Date

Dec 31, 2024
ORGO previous annual earnings announcement was published on Dec 31, 2024

Next Annual Earnings Report Date

N/A
ORGO next annual earnings announcement has not yet been scheduled

OtherORGOcash flowmetrics:

Annual CFF

$27.64 M
ORGO annual cash flow from financing activities is $27.64 million

Annual CFO

$14.21 M
ORGO annual cash flow from operations is $14.21 million

Annual FCF

$4.18 M
ORGO annual free cash flow is $4.18 million

Annual CAPEX

$10.03 M
ORGO annual capital expenditures is $10.03 million

Quarterly CFI

-$3.36 M
-$792.00 K-30.83%

December 31, 2024

Summary

Performance

3-Month Change

-30.83%

1-Year Change

-1.11%

3-Year Change

-1.11%

5-Year Change

+32.2%

ORGO Quarterly CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

29.84%
ORGO quarterly cash flow from investing activities is higher than 29.84% of companies in Healthcare sector

High & Low

All-time High

$0.00
ORGO quarterly cash flow from investing activities is currently <-9900.00% below its historical high of $0.00

3-Year Low

-$10.66 M

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
ORGO previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 9, 2025
ORGO next earnings announcement is scheduled for May 9, 2025

OtherORGOcash flowmetrics:

Quarterly CFF

$33.65 M
ORGO quarterly cash flow from financing activities is $33.65 million

Quarterly CFO

$10.94 M
ORGO quarterly cash flow from operations is $10.94 million

Quarterly FCF

$7.58 M
ORGO quarterly free cash flow is $7.58 million

Quarterly CAPEX

$3.36 M
ORGO quarterly capital expenditures is $3.36 million

TTM CFI

-$10.03 M
-$37.00 K-0.37%

December 31, 2024

Summary

Performance

3-Month Change

-0.37%

1-Year Change

+58.82%

3-Year Change

+58.82%

5-Year Change

+58.57%

ORGO TTM CFI Chart

Add series to chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
series name
Suggested series

Highlights

Sector Rank

35.03%
ORGO TTM cash flow from investing activities is higher than 35.03% of companies in Healthcare sector

High & Low

All-time High

$0.00
ORGO TTM cash flow from investing activities is currently <-9900.00% below its historical high of $0.00

3-Year Low

-$36.12 M

Earnings dates

Last Quarterly Earnings Report Date

Dec 31, 2024
ORGO previous earnings announcement was published on Dec 31, 2024

Next Quarterly Earnings Report Date

May 9, 2025
ORGO next earnings announcement is scheduled for May 9, 2025

OtherORGOcash flowmetrics:

TTM CFF

$27.64 M
ORGO TTM cash flow from financing activities is $27.64 million

TTM CFO

$14.21 M
ORGO TTM cash flow from operations is $14.21 million

TTM FCF

$4.18 M
ORGO TTM free cash flow is $4.18 million

TTM CAPEX

$10.03 M
ORGO TTM capital expenditures is $10.03 million

Cash From Investing Formula

CFI = Cash Inflows from Investments − Cash Outflows for Investments

ORGO Cash From Investing Trends

PeriodPeriodAnnualAnnualQuarterlyQuarterlyTTMTTM
1 y1 year+58.8%-1.1%+58.8%
3 y3 years+67.9%-1.1%+58.8%
5 y5 years-60.9%+32.2%+58.6%

ORGO Cash From Investing Highs & Lows

PeriodPeriodAnnual vs highAnnual vs highAnnual vs lowAnnual vs lowQuarter. vs highQuarter. vs highQuarter. vs lowQuarter. vs lowTTM vs highTTM vs highTTM vs lowTTM vs low
3 y3-yearat high+70.4%-78.8%+68.5%-0.4%+72.2%
5 y5-year-60.9%+70.4%-79.3%+79.9%-60.9%+72.2%
alltimeall time-705.1%+70.4%<-9999.0%+79.9%<-9999.0%+72.2%

Organogenesis Holdings Cash From Investing History

DateAnnualQuarterlyTTM
Dec 2024
-$10.03 M(-58.8%)
-$3.36 M(+30.8%)
-$10.03 M(+0.4%)
Sep 2024
-
-$2.57 M(+36.6%)
-$9.99 M(-25.4%)
Jun 2024
-
-$1.88 M(-15.4%)
-$13.40 M(-29.5%)
Mar 2024
-
-$2.22 M(-33.2%)
-$19.02 M(-21.9%)
Dec 2023
-$24.36 M(-28.1%)
-$3.32 M(-44.4%)
-$24.36 M(-23.1%)
Sep 2023
-
-$5.98 M(-20.3%)
-$31.70 M(-12.2%)
Jun 2023
-
-$7.50 M(-0.8%)
-$36.12 M(+3.8%)
Mar 2023
-
-$7.56 M(-29.0%)
-$34.79 M(+2.6%)
Dec 2022
-$33.90 M(+8.6%)
-$10.66 M(+2.4%)
-$33.90 M(+19.1%)
Sep 2022
-
-$10.40 M(+68.6%)
-$28.47 M(-18.1%)
Jun 2022
-
-$6.17 M(-7.6%)
-$34.77 M(+5.6%)
Mar 2022
-
-$6.67 M(+27.6%)
-$32.94 M(+5.5%)
Dec 2021
-$31.22 M
-$5.23 M(-68.7%)
-$31.22 M(-0.6%)
Sep 2021
-
-$16.70 M(+285.5%)
-$31.41 M(+17.8%)
Jun 2021
-
-$4.33 M(-12.6%)
-$26.67 M(+10.2%)
DateAnnualQuarterlyTTM
Mar 2021
-
-$4.96 M(-8.5%)
-$24.21 M(+3.0%)
Dec 2020
-$23.50 M(+276.9%)
-$5.42 M(-54.7%)
-$23.50 M(+9.1%)
Sep 2020
-
-$11.96 M(+538.0%)
-$21.54 M(+98.5%)
Jun 2020
-
-$1.88 M(-55.8%)
-$10.85 M(+6.8%)
Mar 2020
-
-$4.24 M(+22.7%)
-$10.16 M(+63.0%)
Dec 2019
-$6.23 M(+235.9%)
-$3.46 M(+171.2%)
-$6.23 M(+98.7%)
Sep 2019
-
-$1.27 M(+7.7%)
-$3.14 M(+12.1%)
Jun 2019
-
-$1.18 M(+273.5%)
-$2.80 M(+32.8%)
Mar 2019
-
-$317.00 K(-12.4%)
-$2.11 M(+13.6%)
Dec 2018
-$1.86 M(-87.5%)
-$362.00 K(-61.4%)
-$1.86 M(+24.2%)
Sep 2018
-
-$937.00 K(+90.4%)
-$1.49 M(+168.2%)
Jun 2018
-
-$492.00 K(+656.9%)
-$557.00 K(+756.9%)
Mar 2018
-
-$65.00 K(-94.8%)
-$65.00 K(-94.8%)
Dec 2017
-$14.87 M(+1093.7%)
-
-
Dec 2016
-$1.25 M
-$1.25 M(<-9900.0%)
-$1.25 M(<-9900.0%)
Jun 2016
-
$0.00
$0.00

FAQ

  • What is Organogenesis Holdings annual cash flow from investing activities?
  • What is the all time high annual CFI for Organogenesis Holdings?
  • What is Organogenesis Holdings annual CFI year-on-year change?
  • What is Organogenesis Holdings quarterly cash flow from investing activities?
  • What is the all time high quarterly CFI for Organogenesis Holdings?
  • What is Organogenesis Holdings quarterly CFI year-on-year change?
  • What is Organogenesis Holdings TTM cash flow from investing activities?
  • What is the all time high TTM CFI for Organogenesis Holdings?
  • What is Organogenesis Holdings TTM CFI year-on-year change?

What is Organogenesis Holdings annual cash flow from investing activities?

The current annual CFI of ORGO is -$10.03 M

What is the all time high annual CFI for Organogenesis Holdings?

Organogenesis Holdings all-time high annual cash flow from investing activities is -$1.25 M

What is Organogenesis Holdings annual CFI year-on-year change?

Over the past year, ORGO annual cash flow from investing activities has changed by +$14.33 M (+58.82%)

What is Organogenesis Holdings quarterly cash flow from investing activities?

The current quarterly CFI of ORGO is -$3.36 M

What is the all time high quarterly CFI for Organogenesis Holdings?

Organogenesis Holdings all-time high quarterly cash flow from investing activities is $0.00

What is Organogenesis Holdings quarterly CFI year-on-year change?

Over the past year, ORGO quarterly cash flow from investing activities has changed by -$37.00 K (-1.11%)

What is Organogenesis Holdings TTM cash flow from investing activities?

The current TTM CFI of ORGO is -$10.03 M

What is the all time high TTM CFI for Organogenesis Holdings?

Organogenesis Holdings all-time high TTM cash flow from investing activities is $0.00

What is Organogenesis Holdings TTM CFI year-on-year change?

Over the past year, ORGO TTM cash flow from investing activities has changed by +$14.33 M (+58.82%)